… of the potential therapeutic agent, which displayed better clinical treatment outcomes.
Moreover, with further understanding of the SARS-CoV-2 virus, new drugs targeting specific SARS-…

… There are no available vaccines or antiviral drugs for COVID-19 patients. Herein, we
represented possible therapeutic agents that may stand as a potential therapy against COVID-19. …

… the current evidence of potential therapeutic agents, such as … the efficacy and safety of these
agents in treating COVID-19. … This review focuses on the potential therapeutic agents that …

… different clinical conditions of the disease. Evidence-based reviewing … condition. Therefore,
we performed this review to categorize the coronavirus disease 2019 potential therapeutics …

… and oseltamivir), and supporting agents (Ascorbic acid, Azithromycin, … therapeutic drugs to
prevent, control, and treat COVID-19 patients until the approval of vaccines and specific drugs …

… derived from CQ and both compounds have been used for treating COVID-19 disease [65]. …
anti-COVID-19 drugs, the evidence for their clinical effectiveness is insufficient in COVID-19. …

… antibodies, cytokines, and nucleic acid-based therapies … coronavirus infections, which may
be applicable to COVID-19. The … ongoing development of therapeutic agents and vaccines. …

… The study tests if hydroxychloroquine is successful in preventing symptomatic COVID-19
disease and if it can prevent disease progression in persons. A Phase 3 study is being …

… evaluated for their efficacy in the management of COVID-19 infection. As noted in a recent
… In a trial headed by the Mayo Clinic for COVID-19 disease, CP was used in approximately …

… of SARS‐CoV‐2 and prevention of ischemia/vasoconstriction‐related complications in
COVID‐19 disease, especially in patients with underlying cardiovascular diseases (CVDs). …